Canada-EU Trade Pact

10 02 2011

I have blogged earlier about the ongoing negotiations for a Canada-EU trade deal. One issue that could derail the deal is the whole question of patent life for prescription drugs– the EU would like Canada to extend the period of intellectual property protection for new drugs, an idea opposed by Canada’s generic drug makers and by the provincial ministries of health, which pay for most of the drugs consumed in Canada. According to one estimate, this aspect of the deal could cost Canada $2.8 billion per year.


Actions

Information

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s




%d bloggers like this: